Company Performance Metrics
- Tim McManus: CMO
- Ryan McManus: CEO
Sceptre Surgical develops medical devices for the treatment of implant-related orthopedic infections associated with prosthetic joints and other implants. The company focuses on the clinical challenge posed by bacterial biofilms that form on implant surfaces and resist conventional antibiotics and irrigation. Its flagship patent-pending device, the
Sceptre Brush, integrates mechanical brushing with electrosurgical technology to disrupt and remove biofilm from orthopedic hardware during surgery. The product is intended for use by orthopedic surgeons managing prosthetic joint infections and other implant-associated infections. Sceptre Surgical also supports its device development with basic science studies on biofilm eradication and collaborates with engineering and manufacturing partners to advance its surgical platform.